Metabolomic profiling reveals altered phenylalanine metabolism in Parkinson’s disease in an Egyptian cohort
Nourhan Shebl(American University in Cairo), Mohamed Salama(American University in Cairo), Lobna A. Mohamed(Alexandria University), Hassan A. N. El‐Fawal(American University in Cairo), Omar A. Kittaneh(Effat University), Samir Shamma(American University in Cairo), Mie Rizig(National Hospital for Neurology and Neurosurgery), Rasha Elnemr(Central Laboratory For Agricultural Expert Systems), Amr El-Sayed(American University in Cairo), Passent Elkafrawy(Effat University), Shaimaa I El-Jaafary(Cairo University), Ayman A. Saeed(National Research Centre), Jaidaa Mekky(Alexandria University)
Cited by 17
Related Papers
Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders
|Aging & Mental Health|2018|57
Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial
|Journal of Pain Research|2016|47
The exposome of healthy and accelerated aging across 40 countries
|Nature Medicine|2025|35
Occupational metals exposure and cognitive performance among foundry workers using tau protein as a biomarker
|NeuroToxicology|2019|31
Epilepsy and antiepileptic drugs: risk factors for atherosclerosis
|International Journal of Neuroscience|2014|26